ADVB Advanced Biomed Inc.
Fundamentals / CIK 0001941029 / USDAdvanced Biomed Inc. reported $128K in revenue and net income of $6.07M for the fiscal year ended June 30, 2026, with a -5337.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADVB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026$128K Jun 30, 2026
-
Operating Income FY 2026-$6.81M -5337.5% margin
-
Net Income FY 2026$6.07M 4759.5% net margin
-
Diluted EPS FY 2026$3.68 Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: $33K
Annual revenue and net income
3 fiscal years (2024 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|
| Revenue | $128K | -- | -- |
| Research & Development | -- | $910K | $880K |
| Total Operating Expenses | $6.36M | $1.09M | $2.54M |
| Operating Income | -$6.23M | -$1.09M | -$2.54M |
| EBITDA | -- | -$743K | -$2.14M |
| Interest Income | -- | $25K | $53K |
| Income Before Tax | -$6.26M | -$1.09M | -$2.78M |
| Income Tax Expense | -$1.2K | -- | -- |
| Net Income | $6.68M | -$3.26M | -$2.78M |
| Basic EPS | $5.33 | -$3.18 | -$2.80 |
| Diluted EPS | $5.33 | -$3.18 | -$2.80 |
| Basic Shares Outstanding | 1.3M | 1.0M | 1.0M |
| Diluted Shares Outstanding | 1.3M | 1.0M | 1.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | -- | -- | $243K | $186K | $236K | $310K | $220K | $212K |
| Total Operating Expenses | $974K | $5.05M | $520K | $397K | $147K | $11K | $568K | $280K |
| Operating Income | -$974K | -$4.92M | -$520K | -$397K | -$147K | $227K | -$568K | -$280K |
| EBITDA | -- | -- | -$511K | -$409K | -$99K | $502K | -$545K | -$337K |
| Interest Income | -- | -- | -- | $9.2K | $448 | $9.5K | $26 | $15K |
| Income Before Tax | -$989K | -$12.52M | -$489K | $7.00M | -$147K | $676K | -$1.20M | -$579K |
| Net Income | -$989K | $695K | -$489K | $6.86M | -$387K | -$702K | -$1.38M | -$908K |
| Basic EPS | -$0.60 | -- | -$0.38 | $6.20 | -$0.36 | -- | -$1.35 | -$1.00 |
| Diluted EPS | -$0.60 | -- | -$0.38 | $6.20 | -$0.36 | -- | -$1.35 | -$1.00 |
| Basic Shares Outstanding | 1.7M | -- | 1.3M | 1.1M | 1.1M | -- | 1.0M | 1.0M |
| Diluted Shares Outstanding | 1.7M | -- | 1.3M | 1.1M | 1.1M | -- | 1.0M | 1.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|
| Cash & Cash Equivalents | -- | $2.87M | $2.61M |
| Cash & Short-Term Investments | -- | $2.87M | $2.61M |
| Total Current Assets | $13.75M | $22.38M | $3.05M |
| Property, Plant & Equipment, Net | -- | $125K | $525K |
| Intangible Assets | -- | -- | $119K |
| Other Non-Current Assets | -- | $2.6K | -- |
| Total Non-Current Assets | $1.2K | $480K | $1.41M |
| Total Assets | $13.75M | $22.86M | $4.46M |
| Accounts Payable | -- | $358K | $620K |
| Total Current Liabilities | $1.47M | $19.24M | $2.73M |
| Total Non-Current Liabilities | $0 | $146K | $65K |
| Total Liabilities | $1.47M | $19.38M | $2.80M |
| Total Debt (incl. Leases) | -- | $42K | $127K |
| Common Stock | $1.7K | $1.1K | $20K |
| Retained Earnings | -$12.56M | -$19.23M | -$15.97M |
| Accumulated Other Comp. Income | $969K | $1.34M | $1.12M |
| Total Stockholders' Equity | $12.28M | $3.48M | $1.66M |
| Total Equity | $12.28M | $3.48M | $1.66M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | -- | -- | $2.60M | $2.66M | $2.87M | $5.18M | $2.66M |
| Cash & Short-Term Investments | -- | -- | -- | $2.60M | $2.66M | $2.87M | $5.18M | $2.66M |
| Total Current Assets | $12.87M | $13.75M | $10.53M | $10.73M | $5.84M | $22.38M | $7.73M | $3.14M |
| Property, Plant & Equipment, Net | -- | -- | $87K | $97K | $281K | $125K | $355K | $401K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $20K | $51K |
| Other Non-Current Assets | -- | -- | $2.2K | $956 | $75K | $2.6K | -- | -- |
| Total Non-Current Assets | $35K | $1.2K | $120K | $119K | $399K | $480K | $556K | $1.37M |
| Total Assets | $12.90M | $13.75M | $10.65M | $10.85M | $6.24M | $22.86M | $8.29M | $4.50M |
| Accounts Payable | -- | -- | $377K | $369K | $642K | $358K | $619K | $618K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $690K |
| Total Current Liabilities | $1.59M | $1.47M | $1.43M | $1.25M | $3.04M | $19.24M | $4.11M | $3.83M |
| Total Non-Current Liabilities | $24K | $0 | $11K | $115K | $194K | $146K | $44K | $56K |
| Total Liabilities | $1.61M | $1.47M | $1.44M | $1.37M | $3.24M | $19.38M | $4.16M | $3.89M |
| Total Debt (incl. Leases) | $33K | -- | $30K | $21K | $31K | $42K | $183K | $290K |
| Common Stock | $1.7K | $1.7K | $1.4K | $22K | $22K | $1.1K | $22K | $20K |
| Retained Earnings | -$13.55M | -$12.56M | -$13.25M | -$12.76M | -$19.62M | -$19.23M | -$18.53M | -$17.15M |
| Accumulated Other Comp. Income | $969K | $969K | $844K | $875K | $1.26M | $1.34M | $1.29M | $1.25M |
| Total Stockholders' Equity | $11.29M | $12.28M | $9.21M | $9.48M | $3.00M | $3.48M | $4.13M | $619K |
| Total Equity | $11.29M | $12.28M | $9.21M | $9.48M | $3.00M | $3.48M | $4.13M | $619K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|
| Net Income | $6.68M | -$3.26M | -$2.78M |
| Depreciation & Amortization | -- | $344K | $400K |
| Stock-Based Compensation | $1.73M | -- | -- |
| Operating Cash Flow | -$1.95M | -$5.83M | -$2.13M |
| Capital Expenditure | -- | -$32K | -$74K |
| Free Cash Flow | -- | -$5.86M | -$2.20M |
| Investing Cash Flow | -$2.51M | -$32K | -$74K |
| Common Stock Issued | $248K | $5.49M | -- |
| Financing Cash Flow | $1.97M | $5.93M | $1.87M |
| Net Change in Cash | -$2.52M | $296K | -$14K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$989K | $695K | -$489K | $6.86M | -$387K | -$702K | -$1.38M | -$908K |
| Depreciation & Amortization | -- | -- | $9.3K | -$13K | $48K | $276K | $23K | -$57K |
| Operating Cash Flow | -$171K | -$583K | -$240K | -$514K | -$610K | -$1.54M | -$3.41M | -$842K |
| Capital Expenditure | -- | -- | -$1.3K | -$13K | -$1.8K | -$20K | -$2.2K | $11K |
| Free Cash Flow | -- | -- | -$241K | -$526K | -$612K | -$1.56M | -$3.41M | -$831K |
| Investing Cash Flow | -- | -$2.49M | -$1.3K | -$13K | -$1.8K | -$20K | -$2.2K | $11K |
| Financing Cash Flow | -- | $937K | $268K | $315K | $447K | -$765K | $5.90M | $408K |
| Net Change in Cash | -$172K | -$2.22M | -$2.0K | -$46K | -$247K | -$2.28M | $2.53M | $10K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|
| Operating Margin | -4883.8% | -- | -- |
| Net Profit Margin | 5231.3% | -- | -- |
| Return on Equity (ROE) | 54.4% | -93.7% | -167.3% |
| Return on Assets (ROA) | 48.6% | -14.3% | -62.4% |
| Current Ratio | 9.33x | 1.16x | 1.12x |
| Quick Ratio | -- | 0.15x | 0.95x |
| Debt to Equity | -- | 0.01x | 0.08x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 53.8% | 54.4% | 57.3% | 46.3% | -112.5% | -93.7% | -- | -- |
| Return on Assets (ROA) | 47.1% | 48.6% | 49.6% | 40.4% | -54.1% | -14.3% | -- | -- |
| Current Ratio | 8.09x | 9.33x | 7.38x | 8.56x | 1.92x | 1.16x | 1.88x | 0.82x |
| Quick Ratio | -- | -- | -- | 2.08x | 0.87x | 0.15x | 1.26x | 0.69x |
| Debt to Equity | 0.00x | -- | 0.00x | 0.00x | 0.01x | 0.01x | 0.04x | 0.47x |
| Operating Income Growth (YoY) | -- | -2272.1% | -- | -- | -- | -- | -- | -- |